T reatment of mice with deoxycorticosterone acetate (DOCA)-salt is a model of hypertension attributed to low circulating but elevated brain renin-angiotensin system activity. Implicating the mechanistic involvement of the brain reninangiotensin system are studies showing that central injection of either angiotensin-converting enzyme inhibitors or angiotensin II (Ang-II) type 1 receptor (AT 1 R) blockers into the brain either prevent or reverse DOCA-salt hypertension.
T reatment of mice with deoxycorticosterone acetate (DOCA)-salt is a model of hypertension attributed to low circulating but elevated brain renin-angiotensin system activity. Implicating the mechanistic involvement of the brain reninangiotensin system are studies showing that central injection of either angiotensin-converting enzyme inhibitors or angiotensin II (Ang-II) type 1 receptor (AT 1 R) blockers into the brain either prevent or reverse DOCA-salt hypertension.
1-3 DOCA-salt also causes an increased resting metabolic rate, which can be significantly blunted by an AT 1 R blocker. 4, 5 The subfornical organ (SFO) is a circumventricular organ that plays an important role in the regulation of fluid balance, cardiovascular regulation, and energy metabolism. 6, 7 The SFO is a sensory brain structure, which lies outside of the bloodbrain barrier and relays information about the constitution of cerebral spinal fluid to other parts of the central nervous system. 8 The SFO expresses angiotensinogen, the substrate for Ang-II, and is also rich in AT 1 R. 9, 10 Ablation of angiotensinogen production in the SFO prevents the pressor and dipsogenic responses to increased Ang-II production in the brain.
Recent evidence suggests that endoplasmic reticulum (ER) stress in the SFO contributes to the development of hypertension. Young et al 14 showed that intracerebroventricular infusion of the ER stress-inducing chemical thapsigargin caused hypertension. They further demonstrated that subcutaneous infusion of Ang-II at a dose that increases arterial pressure gradually over time caused ER stress in the SFO as detected by increased expression of ER stress biomarkers and ultrastructural abnormalities in the ER. The mechanistic association between brain ER stress and hypertension was demonstrated by showing that the hypertension induced by Ang-II could be prevented by treatment with a chemical chaperone or by SFOdirected expression of GRP78, the most abundant ER-resident chaperone.
The ER is a membranous organelle, which has its main function directing the synthesis and folding of proteins. Secretory proteins and resident proteins of the endomembrane system are translocated into the ER lumen, where they are folded, oxidized, and glycosylated before export to the Golgi for further modification and transit to their final destinations. Approximately one third of the cellular proteome is folded in the ER, and an excess of ER client proteins or a perturbation that disrupts ER protein folding can induce ER stress and activate an adaptive signaling cascade known as the unfolded protein response (UPR). The UPR has been comprehensively reviewed. 15, 16 The UPR acts to restore ER homeostasis in several ways, including selective inhibition of protein synthesis, increased synthesis of ER-resident chaperones, and increased degradation of unfolded proteins. It is becoming clear that the UPR is activated by normal physiological stimuli, and thereby contributes to the maintenance of physiological homeostasis. 17 In addition, several pathophysiological conditions, including diabetes mellitus, cancer, and cardiovascular disease, have been associated with excessive or persistent ER stress, which is thought to contribute to the disease phenotype. [18] [19] [20] [21] Persistent ER stress can contribute to pathophysiology both by inciting cell death and by leading to dysregulation of redox balance, inflammatory cascades, metabolism, and other physiological processes. 17, [22] [23] [24] [25] Many of these responses are mediated by the stress-regulated transcription factor CCAAT homologous binding protein (CHOP), the persistent expression of which promotes accumulation of reactive oxygen species and cell death. 25 Accordingly, animals lacking CHOP are protected from a wide array of diseases in which ER stress is implicated. [26] [27] [28] [29] Given the link between ER stress in the SFO and Ang-IIinduced hypertension, the importance of AT 1 R in the SFO in mediating responses to DOCA-salt, and the association of DOCA-salt hypertension with increased brain renin-angiotensin system activity, we hypothesized that the cardinal dipsogenic, pressor, and metabolic responses to DOCA-salt might mechanistically involve brain ER stress, and more specifically, ER stress in the SFO. 1, 2, 13 Moreover, CHOP plays a pivotal role in mediating ER stress, and CHOPdeficient mice are protected from diabetes mellitus, diabetic nephropathy, and atherosclerosis. 27, 30, 31 Consequently, the purpose of this study was to determine whether DOCAsalt hypertension is associated with ER stress in the SFO, whether blocking ER stress reduces the cardinal phenotypes associated with DOCA-salt hypertension, and whether CHOP plays a mechanistic role in mediating physiological responses to DOCA-salt.
Methods
Specific surgical and pharmacological protocols and detailed methods are provided in the expanded Methods in the online-only Data Supplement.
Animals
All studies were approved by the University of Iowa Animal Care and Use Committee and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Standard laboratory chow (Harlan Teklad, NIH-31 modified 6% mouse diet) and tap water were provided ad libitum until the experiments involving DOCA were initiated. Mice used in the study included 6-week-old wild-type C57BL/6J mice and CHOPdeficient mice that were highly backcrossed (>10 generations) into the C57BL/6J line and maintained by homozygous breeding. 32 Consequently, age-and sex-matched C57BL/6J were used as controls.
Statistics
We analyzed the data with 1-or 2-way ANOVA, with repeated measurements as appropriate. Bonferroni multiple comparisons procedures were used to explore treatment effects. If equal variance or normality failed, we used nonparametric analysis of our data, such as Mann-Whitney U or Wilcoxon tests. We considered differences significant at P<0.05.
Results

Differential Mean Arterial Blood Pressure, Heart Rate, and Drinking Responses to ER Stress Reduction
Our initial rationale was to determine whether alleviating ER stress specifically in the brain would alter the changes in mean arterial blood pressure (MAP), heart rate (HR), and salineintake associated with DOCA-salt-induced hypertension. To do this, we administered the chemical chaperone tauroursodeoxycholic acid (TUDCA) by intracerebroventricular infusion and then examined the changes in MAP and HR induced by DOCA-salt by radiotelemetry. Baseline MAP and HR were the same and displayed normal circadian periodicity in the groups destined for artificial cerebrospinal fluid or TUDCA ( Figure 1A ). After 3 weeks of DOCA-salt, mice treated only with intracerebroventricular artificial cerebrospinal fluid exhibited a 14±5-mm Hg increase in MAP ( Figure 1B) . TUDCA had no effect on this response ( Figure 1B and 1C) . DOCA-salt led to an 80±15 bpm reduction in HR, which was significantly attenuated by TUDCA ( Figure 1C) .
Next, we examined the saline-intake response to TUDCA in DOCA-salt and sham mice using the protocol diagrammed in Figure S1 in the online-only Data Supplement. There were no changes in body weight in response to TUDCA or 4-phenylbutyrate (4PBA; Figure S2 ). Before intracerebroventricular artificial cerebrospinal fluid or TUDCA, DOCA-salt-treated mice exhibited a significant increase in saline-intake compared with sham mice (Figure 2A ). Intracerebroventricular TUDCA had no effect on saline-intake in sham mice. In contrast to its effect on MAP, intracerebroventricular TUDCA significantly attenuated saline-intake in DOCA-salt-treated mice. The decrease in saline-intake was maintained for as long as the daily intracerebroventricular injections of TUDCA were maintained, and saline-intake increased to pre-TUDCA levels 1 day after TUDCA was discontinued. There was no decrease at Cornell University--Ithaca on May 21, 2015 http://hyper.ahajournals.org/ Downloaded from in saline-intake when TUDCA was infused IP ( Figure 2B ). The decrease in saline-intake was not specific to TUDCA, as another chemical chaperone, 4PBA, similarly decreased DOCA-saltinduced saline-intake ( Figure 2C ). The blunted saline-intake response to DOCA-salt induced by TUDCA was replicated in a second independent cohort of mice housed in metabolism cages and was accompanied by decreased urine output ( Figure S3 ). These results suggest that DOCA-salt induces ER stress in the brain that contributes to the saline-intake and HR responses but not the pressor response caused by DOCA-salt.
DOCA-Salt Causes ER Stress in the SFO and Supraoptic Nuclei
Given the response to chemical chaperones and the importance of the SFO in mediating saline-intake responses to DOCA-salt, 13, 33, 34 we next tested whether DOCA-salt induces ER stress in the SFO by measuring CHOP, a key protein increased in response to ER stress. Background immunoreactivity was detected in the SFO of untreated C57BL/6J control mice and CHOP-deficient mice ( Figure 3 ). DOCA-salt caused a marked elevation in CHOP immunoreactivity in the SFO, which was similar in magnitude to that caused by tunicamycin and Ang-II ( Figure 3 ). There was virtually no staining for CHOP outside the SFO except for occasional cells in the supraoptic nuclei (SON) and lateral hypothalamus ( Figure 3) , consistent with the importance of the SON in mediating drinking responses to Ang-II. There was no increase in CHOP detected in the remainder of the hypothalamus and the thalamus, preoptic area, cortex, and basal ganglia.
The presence of ER stress in the SFO was next validated by ultrastructural analysis using electron microscopy. The Saline-intake responses to endoplasmic reticulum stress blockade. A, Daily saline-intake was measured in sham and deoxycorticosterone acetate (DOCA)-salt-treated mice before and after daily intracerebroventricular (ICV) artificial cerebrospinal fluid (aCSF) or tauroursodeoxycholic acid (TUDCA). *P<0.05 vs aCSF; πP<0.05 vs sham. B, Daily saline-intake was measured in DOCA-salttreated mice before and after daily intraperitoneal saline or TUDCA. C, Saline-intake was measured in DOCA-salt-treated mice before and after ICV aCSF or 4-phenylbutyrate (4PBA). These data represent the average of 2 days of measurements taken 6 to 7 days after 4PBA was started. *P<0.05 vs baseline and aCSF. In all experiments, baseline was the average of 3 days of measurements. All measurements were performed in the home cage. Group sizes are indicated. All data are mean±SEM.
rough ER appeared normal with extensive parallel membranes in neurons (Figure 4 ), glia ( Figure S4 ), and ependymal cells ( Figure S5 ) in the SFO of control mice. Large numbers of ribosomes were observed attached to the rough ER and free in the cytoplasm. In contrast, the rough ER was broken up into short lengths with numerous swellings or vacuole-like structures in all 3 cells types after DOCA-salt. Little of the ER had ribosomes attached, and there were few free ribosomes in the cytoplasm. In addition, numerous large vacuoles were observed in the cytoplasm, in glia, and in ependymal cells.
Attenuating ER Stress in the SFO Decreases Saline-Intake
To test the role of ER stress in the SFO in mediating the enhanced saline-intake response to DOCA-salt, we specifically targeted overexpression of GRP78 (also known as BiP), the most abundant resident ER chaperone, to the SFO using an adenovirus, after first confirming that we can specifically infect the SFO using AdeGFP ( Figure S6 ). AdGRP78 had no effect on body weight at baseline or in the sham mice ( Figure S7 ). However, SFO-directed GRP78 lowered body weight by 1.5 g in DOCA-salt-treated mice. Similar to the effects of chemical chaperone treatment, SFO-specific GRP78 decreased saline-intake in DOCA-salt mice but had no effect in sham mice ( Figure 5 ). These data implicate ER stress in the SFO as partially mediating the increase in salineintake induced by DOCA-salt.
Role of CHOP in Mediating Cardinal Phenotypes of DOCA-Salt
Seeing the increase in CHOP immunocytochemistry in the SFO, we next asked whether CHOP plays a functional role in mediating responses to DOCA-salt. CHOP-deficiency had no effect on baseline saline-intake ( Figure 6A ), or systolic blood pressure ( Figure 6B ) but caused a modest tachycardia ( Figure  S8 ). Saline-intake was blunted in DOCA-salt-treated CHOPdeficient mice ( Figure 6A ). Systolic blood pressure was similar comparing DOCA-salt-treated C57 and CHOP-deficient mice ( Figure 6B ). The bradycardia caused by DOCA-salt was amplified in CHOP-deficient mice ( Figure S8 ). We previously reported that DOCA-salt increases resting metabolic rate, a finding replicated here ( Figure S9) . 4, 5 Interestingly, resting metabolic rate was elevated under baseline conditions in CHOP-deficient mice, which resulted in a blunted response to DOCA-salt ( Figure S9 ).
Discussion
The main findings of this study are that DOCA-salt results in (1) ER stress in the SFO and SON, (2) relief of ER stress in the brain by chemical chaperone or in the SFO by adenoviral transduction of a resident molecular chaperone decreases saline-intake, but not arterial blood pressure, (3) CHOP may play a mechanistic role in mediating saline-intake in response to DOCA-salt, and (4) CHOP may be involved in regulating HR and resting metabolic rate. These data lead us to conclude that DOCA-salt causes ER stress in the brain, specifically in the SFO and SON, which is mechanistically linked to increased saline-intake but not hypertension. Thus, the increase in salineintake and arterial pressure by DOCA-salt is mediated by mechanistically distinct intracellular signaling processes that can be separated by the effect induced by ER stress.
The evidence supporting a mechanistic contribution of ER stress to DOCA-salt-induced saline-intake is supported by the at Cornell University--Ithaca on May 21, 2015 http://hyper.ahajournals.org/ Downloaded from decrease in saline-intake in response to 2 chemically distinct chaperones injected directly into the brain. Because both agents had their effect when injected intracerebroventricular, we cannot determine where in brain these agents had their primary effect. It is likely that both agents gained access to regions of the brain outside the blood-brain barrier such as the SFO and other circumventricular organs. However, despite being small molecular weight chemicals (both <500 daltons), it is unclear whether they gain access to the brain parenchyma. That TUDCA-injected systemically had no effect on saline-intake strongly suggests that its effect is mediated by relieving ER stress in the brain. Along these lines, it is interesting to note that similar doses of TUDCAinjected intraperitoneal decreased Aβ amyloid deposition in the brain of an Alzheimer disease mouse model and reduced microglial activation in a model of acute neuroinflammation. 35, 36 Thus, the difference in efficacy of intraperitoneal versus intraventricular TUDCA remains difficult to explain. It is also notable that saline-intake rapidly returned to normal 1 day after discontinuing TUDCA. Thus, it is possible that a continuous relatively high local concentration of TUDCA may be required to relieve ER stress in the face of continuous DOCA and high salt.
Immunohistochemistry revealed that DOCA-salt elevated the level of CHOP protein in both the SFO and the SON, most strongly and consistently in the SFO. The increase in CHOP in the SFO was anticipated for 2 reasons. First, ER stress in the SFO was previously implicated in mediating the hypertensive response to Ang-II infusion.
14 Second, Ang-II AT 1 Rs in the SFO are required to mediate fluid and sodium intake responses to DOCA-salt. 13 These data are consistent with the well-established role of the SFO in the regulation of salt and water intake. 37 Although evidence for ER stress in the SON (as suggested by increase CHOP) was not originally anticipated, it is consistent with its known function to regulate fluid and electrolyte balance through arginine vasopressin. 38 Because the SON contains osmosensitive projections from the SFO, 39 it will be interesting to assess in future studies whether the increase in CHOP immunoreactivity in the SON is restricted to the osmosensitive neurons, which project from the SFO. The SFO has a distinctive structure, which allows it to sample the chemical constituents of the cerebrospinal fluid and is uniquely positioned with afferent and efferent connections, which allows it to integrate both blood-borne and CNS-derived signals. 40 This may make the SFO particularly sensitive to those agents that cause ER stress, such as Ang-II, tunicamycin, and as shown here DOCA-salt. A recent study using optogenetics to directly stimulate action potentials in SFO neurons revealed that the increase in water intake occurs virtually immediately after stimulation. 41 Consequently, additional studies will have to mechanistically determine how DOCA-salt-induced ER stress, which likely develops over time, induces activity of SFO neurons.
It is noteworthy that despite the increase in CHOP immunoreactivity, we were unable to detect a clear difference in CHOP gene expression in the SFO of DOCA-salt-treated mice (data not shown). However, it was recently reported that increased expression of the mRNAs encoding several ER stress biomarkers (s-XBP, ATF4, GRP78 [also known as BiP], and CHOP) was evident in the SFO and to a lesser extent the paraventricular nucleus of DOCA-salt-treated mice. 42 However, unlike their study, which surprisingly concluded that ER stress does not occur in the SFO in response to DOCA-salt, our identification of increased CHOP protein in the SFO (and SON) concomitant with ultrastructural changes consistent with ER stress and decreased saline-intake in response to SFO-targeted delivery of AdGRP78 provide compelling evidence for the induction of ER stress in the SFO in response to DOCA-salt.
Perhaps the most interesting finding was that relieving ER stress with TUDCA attenuated DOCA-salt-induced salineintake but not hypertension. Whereas the absence of an effect on blood pressure is consistent with a previous report observing no changes in DOCA-salt-induced blood pressure in response to TUDCA, 42 it stands in contrast to 2 other studies where relief of ER stress prevented the hypertensive response in Ang-II 14 and reduced blood pressure in the spontaneously hypertensive rat. 43 Assuming that there are no technical limitations in both DOCA-salt studies, these results have 2 main implications. First, ER stress may play a role in the pathogenesis of some forms of hypertension (eg, Ang-II and some forms of genetic hypertension), but not others (eg, DOCA-salt hypertension). Chemical chaperones also relieve pulmonary hypertension in some models. 44, 45 Additional studies will be required to assess the full range of experimental and genetic models of hypertension, which involve an ER stress component. Of course, we cannot rule out the possibility that DOCA-salt causes ER stress in a region of the brain, which cannot be accessed by intracerebroventricular TUDCA, perhaps the brain stem. Indeed, the rostral ventrolateral medulla has been implicated as an important region mediating DOCA-salt hypertension. 46 It is also interesting to speculate that the renin/Ang-II status of the model is important in determining a response to relief of brain ER stress. DOCA-salt is a model of low renin/Ang-II hypertension, whereas the Ang-II infusion model and SHR represent models of high and normal Ang-II hypertension, respectively.
The second and perhaps more important implication is that ER stress may be a mechanism that distinguishes some of the common phenotypes observed concurrently in hypertension. In the case of the DOCA-salt model, we refer to the increased saline-intake, which predates and then accompanies hypertension. Because blood pressure was not reduced concomitantly with saline-intake by TUDCA, it might be tempting to speculate that increased saline-intake is not necessary for the development or maintenance of DOCA-salt hypertension. However, it is well established that both DOCA and high salt are required to mediate hypertension in this model. 47 Blood pressure and saline-intake studies were performed in independent cohorts of mice; and 1 potential limitation of our study was that we used different protocols to study the blood pressure and saline-intake responses to TUDCA, intracerebroventricular minipump in the former and daily intracerebroventricular injections in the latter.
It is interesting that the reduction in saline-intake, but not blood pressure, induced by TUDCA-mediated relief of ER stress, was paralleled in studies examining mice deficient in CHOP. CHOP-deficient mice exhibited a modest but significant decrease in DOCA-salt-induced saline-intake, but no change in the hypertensive response to DOCA-salt. Thus, whereas the blood pressure response to DOCA-salt is preserved in CHOP-deficient mice, the saline-intake response is impaired. This suggests the possibility that the full extent of saline-intake induced by DOCA-salt requires ER stress mediated partly through CHOP, and that CHOP is dispensable for DOCA-salt-induced hypertension. CHOP is a transcription factor which, with other transcription factors, participates in the transcriptional response to ER stress by increasing and decreasing the expression of other target genes. CHOP expression is induced by the PERK/eiF2/ATF4 and ATF6 branches of the UPR. CHOP and XBP1 are concomitantly induced and both were reportedly induced in the SFO in response to DOCA-salt. 42 It is well established that prolonged activation of CHOP can induce apoptosis. 25, 48 We have no evidence addressing whether apoptosis is occurring in the brain of DOCA-salt mice and whether this is worsened in regions showing evidence of ER stress, such as the SFO and SON. It is also unclear whether DOCA-salt-treated CHOP-deficient mice are protected from ER-stress-induced apoptosis. There is precedence for protection because CHOP-deficient mice were reported to be protected from neuronal apoptosis induced by ischemia, and primary hippocampal neurons from these mice were protected from hypoxia-reoxygenation-induced apoptosis. 49 Consequently, studies directly examining whether apoptosis or apoptosis signaling cascades are activated/repressed would be warranted.
Perspectives
ER stress in the brain has become a new mechanistic paradigm associated with Ang-II-dependent hypertension and has been reported in at least 1 model of genetic hypertension. 14, 43 Our studies suggest that ER stress also occurs in the DOCA-salt model of hypertension but that relief of ER stress by chemical chaperones does not lower blood pressure as it does in other models. However, chemical chaperones strongly blunted the saline-intake, which occurs concomitantly in DOCA-salt hypertension. Although our study focused solely on the brain, ER stress has been reported to occur in endothelial dysfunction, atherosclerosis, in several renal disorders, and in the placenta in preeclampsia. 19, 50, 51 Thus, it is likely that like oxidative stress, ER stress plays an important role in the pathogenesis of at least some forms of hypertension. Nevertheless, it remains unclear whether ER stress plays an important mechanistic role in human essential hypertension and whether either chemical or molecular chaperones will become effective treatments for hypertension.
What Is New?
• Deoxycorticosterone acetate (DOCA)-salt hypertension is associated with endoplasmic reticulum (ER) stress in the subfornical organ and supraoptic nuclei as evidenced by increased CCAAT homologous binding protein immunoreactivity in both nuclei and altered ultrastructure of the ER in the subfornical organ.
• Relief of ER stress by brain-specific administration of chemical chaperones decreases DOCA-salt-induced saline-intake but not hypertension.
• Relief of ER stress in the subfornical organ by targeted delivery of AdGRP78 decreases DOCA-salt-induced saline-intake.
• CCAAT homologous binding protein-deficient mice exhibit blunted DOCA-salt-induced saline-intake.
What Is Relevant?
• ER stress is an essential component of DOCA-salt-induced saline-intake.
• CCAAT homologous binding protein and its transcriptional pathway may play a mechanistic role in mediating increased drinking in the DOCA-salt model of hypertension.
Summary
We conclude that (1) brain ER stress mediates the saline-intake, but not blood pressure response to DOCA-salt, (2) DOCA-salt causes ER stress in the subfornical organ which when attenuated by GRP78 blunts saline-intake, and (3) CCAAT homologous binding protein may play a modest functional role in DOCA-salt-induced saline-intake. The results suggest a mechanistic distinction between the importance of ER stress in mediating effects of DOCAsalt on saline-intake and blood pressure.
Novelty and Significance
Supplemental Methods
Surgery. Mice were instrumented with an indwelling lateral intracerebroventricular (ICV) cannula (PlasticsOne Inc.) for brain injection of pharmacological agents or virus as previously described. 1 The animals were anesthetized (ketamine, 150 mg/kg + xylazine, 15 mg/kg, IP), placed in a stereotaxic device and the dorsal surface of the skull was visualized under a dissecting microscope. Stereotaxic coordinates for the placement of the ICV cannula were 0.2 mm rostral, 1.0 mm lateral to Bregma and 2.3 mm ventral from the dorsal surface of the skull.
The guide cannula was anchored to the skull with three stainless steel screws and dental cement.
A cannula dummy was inserted into the guide cannula to prevent blockage of the guide cannula prior to intracerebroventricular (ICV) injection. Some mice also received a 50mg pellet of DOCA (Sigma-Aldrich) implanted subcutaneously. 2, 3 For mice that did not undergo implantation of the ICV cannula, a 50mg pellet of DOCA (Sigma-Aldrich) was implanted subcutaneously under isoflurane anesthesia. Following surgery, mice were individually housed and were given several days to recover prior to ICV administration of pharmacological agents and/or other experimental measurements. Ang-II was administered at a dose of 1000ng/kg/hr subcutaneously through a minipump for 14 days as described previously. 4 Recombinant adenoviral vectors encoding 78 kDa glucose-regulated protein (AdGRP78, 6x10 7 plaque-forming units/ml), and titer-matched AdLacZ or AdeGFP were previously reported and obtained from the University of Iowa Gene Transfer Vector Core (IGTVC). 5 After seven days recovery from ICV cannula surgery, mice were injected with either AdGRP78 (6x10 4 plaque forming units in 1μl) or titer matched AdLacZ as previously reported. 1, 3 Following the ICV procedure, mice were placed into home cages and daily saline intake and body weight were measured. As a control to validate SFO-specific targeting, a C57BL/6 mouse receiving ICV AdeGFP was sacrificed 12 days after injection. Following the perfusion and fixation procedure, the brain was cut into 50μm sections using a vibratome. Sections containing the SFO and other cardiovascular control regions were immediately put on the slide glass and observed under fluorescence microscope.
2,6
Intake Behaviors. Intake behaviors were measured either in the home cage or in metabolism cages. After surgery to implant the ICV catheter and the DOCA pellet, the mice were allowed to recover and were provided ad libitum access to standard chow (Harlan Teklad) by radiotelemetry (TA11PA-C10; Data Sciences International, DSI) were performed as described previously.
2,3
Briefly, mice were implanted with radiotelemeters into the common carotid artery while under ketamine/xylazine anesthesia. Following a week of recovery, spontaneous physical activity, blood pressure, and heart rate were recorded every 10 seconds for 5 minutes using Dataquest software (DSI) as "baseline" data. Mice then underwent a second surgery to implant an ICV cannula for chronic infusion of either aCSF or TUDCA (5.28 ug/day) using osmotic minipump. DOCA pellets were implanted subcutaneously and mice were allowed ad libitum access to both water and 0.15 M NaCl drink solution. Three weeks later, "on DOCA-salt" data were recorded. Any mouse with a poor radiotelemeter signal, pulse pressure below 15 mmHg, or a systolic BP above 200 mmHg (indicative of an occluded catheter) was excluded from further analysis.
For tail cuff measurements, mice were acclimated to the tail-cuff apparatus (Visitech Systems BP-2000) for 1 week. After acclimation, 2-weeks of baseline measurements were taken.
Once baseline measurements were obtained, mice were implanted with DOCA, provided ad libitum access to both water and 0.15 M NaCl drink solution and then daily measurements continued for another 21 days. The last 14 days of data were used as DOCA-salt treatment.
Each daily measure consisted of the average of 30 measurements inflations.
Resting metabolic rate was assessed by indirect calorimetry. 7 Briefly, room air was drawn through a water-jacketed, 2L chamber (Ace Glass, Vineland, NJ) maintained at 30°C (thermo neutrality), and oxygen (S-3A/II, AEI Technologies) and carbon dioxide (CD-31, AEI Technologies) concentrations were determined in effluent air. Data were recorded and analyzed using Power Lab (AD Instruments) and the associated Chart software.
Immunohistochemistry and electron microscopy. Mice (n=17 per group) were perfused transcardially with 4% paraformaldehyde in 0.1 M PBS (pH 7.4) under deep anesthesia (ketamine, 150mg/kg+xylazine,15mg/kg, IP), and the brain was removed and post-fixed overnight in the same fixative, followed by 30% sucrose solution for at least 2 days. Twenty micron coronal sections of the brain were cut using a vibratome. Sections were rinsed for 30 minutes in PBS. After pre-absorption in normal horse serum (5%) and Triton-X 100 (0.1%) in PBS, the sections were incubated with a mouse monoclonal antibody against CHOP (1:500;
Santa-Cruz Biotechnology) at 4 °C overnight and then rinsed 3 times in PBS. Control and experimental samples were incubated with the primary antibody in the same chamber. After incubation in normal horse serum (1%), anti-mouse IgG made in goat, and triton-X 100 (0.1%) in PBS for 1 hour, the sections were rinsed 3 times in PBS and incubated with the AB complexes for 30 minutes (Vectastain ABC elite kit, Vector Laboratories, Burlingame, CA). This was followed by washing the sections 3 times in PBS and incubating with DAB substrate kit for 2 minutes (Vector Laboratories). Sections were mounted and observed under a light microscope (Nikon, Tokyo, Japan).
Eight animals (n=4 from each group) were perfused with 0.9% saline followed by an ice-cold fixative consisting of 1% glutaraldehyde and 4% paraformaldehyde in phosphate buffer (pH 7.2, 0.167M). Brains were removed and cut into 50 micron thick sections. Sections containing the subfornical organ were osmicated (0.5% osmic acid in distilled water), dehydrated in acetone, and flat-embedded in Epon 812. Under a dissecting microscope, the embedded SFO was cut out from 3 or 4 sampled sections from each animal and mounted on Epon bullets. Ultrathin sections were cut with a diamond knife, mounted on Formvar-coated grids and stained with uranyl acetate and lead citrate and examined using a Hitachi electron microscope. Several grids from each section from each animal were examined and selected neurons, glia and ependymal cells photographed. A total of 70 photographs were taken.
